Vanguard Group Inc BRAINSTORM CELL THERAPEUTICS Transaction History

Vanguard Group Inc

  • $5.37 Trillion
  • Q1 2025
Number of Shares
27,724
Previous 78,441 64.66%
Holding current value
$0
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 09, 2025
SELL
N/A
-50,717 Reduced 64.66%
27,724 $0
Q4 2024

Feb 11, 2025
BUY
N/A
78,441 New
78,441 $0
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email